Skip to content

Effect of Oregano nasal spray on migraine

Effect of an herbal nasal spray (an Iranian traditional medicine drug) based on oregano on migraine: A randomized, double-blinded, clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220601055051N1
Enrollment
70
Registered
2023-02-03
Start date
2023-02-09
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine headache. G43.0Migraine without aura [common migraine]

Interventions

Intervention 1: Intervention group: herbal nasal spray based on oregano- three times a day one puff each nasal orifice. Intervention 2: Control group: placebo nasal spray-three times a day one puff ea

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Migraine based on IHS criteria 2 to 8 migraine attack in a month with less than 15 days headache a month and with at least 48 hours intervals Onset of headaches less than one year ago No warm brain temperament 18 to 65 years old with headache onset no later than 50 years old

Exclusion criteria

Exclusion criteria: Secondary headaches Regular use of antipsychotic or antidepressant drugs during last 3 months for reasons other than migraine Alcohol or drug abuse Drug sensitivity to the drug ingredients Fertile women with no contraception Pregnancy and breast feeding consuming drugs affecting migraine headache or interacting with drug ingredients during last week Analgesic overuse based on IHS criteria Severe physical or psychologic disease

Design outcomes

Primary

MeasureTime frame
Number of migraine headache attacks per month. Timepoint: Three times with one month intervals. Method of measurement: Number of attacks with at least 48 hours of freedom from headache between migraine attacks.

Secondary

MeasureTime frame
Headache severity. Timepoint: Tree times with one month intervals. Method of measurement: Four point verbal scale.;Number and name of analgesics used. Timepoint: Three times with one month intervals. Method of measurement: Recording the name and the number of analgesics used in one month.;Health related quality of life. Timepoint: Three times with one month intervals. Method of measurement: Sf 36 & hit 6 questionaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJila Naseri

Tehran University of Medical Sciences

j_n_30@yahoo.com+98 21 8899 3656

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026